Grifols family to step away further from operations; enGene CEO resigns, citing health reasons
16 Feb 2024
Executive Change
→ Spanish plasma giant
Grifols
will institute more big changes at the top — and the family ties have loosened considerably once again.
Nacho Abia
takes over for
Thomas Glanzmann
as CEO on April 1, while
Raimon Grifols
and
Víctor Grifols Deu
— the father-son duo who had been co-CEOs from 2017-23 — will no longer be chief corporate officer and COO, respectively. Glanzmann
had held the top spot
since last May and will continue as executive chairman. The moves have been brewing since 2022,
according to a press release
. “The Board awaited activation until the company’s post-pandemic recovery had solidified,” it says. Both members of the family will keep their seats on the board as “proprietary directors.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.